A monthly snapshot of FDA activity involving therapies for the prevention and treatment of neurologic diseases.
In Canada, between 3,000 and 4,000 people are living with amyotrophic lateral sclerosis (ALS), a disease that remains ...
Scientists discovered that certain gene changes allow cells to function even when frataxin, the protein lost in Friedreich’s ataxia, is missing. Experiments in worms, human cells, and mice revealed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results